Actinogen Medical Ltd
F:3AC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Actinogen Medical Ltd
F:3AC
|
AU |
|
Addex Therapeutics Ltd
F:APE
|
CH |
|
G
|
GH Research PLC
F:1KA
|
IE |
|
Inghams Group Ltd
ASX:ING
|
AU |
|
A
|
Andritz AG
XMUN:AZ2
|
AT |
|
C
|
Citigroup Inc
BMV:C
|
US |
|
D
|
Donnelley Financial Solutions Inc
F:1DN
|
US |
|
Z
|
ZIGUP PLC
F:21W
|
UK |
|
B
|
Bougainville Copper Ltd
XMUN:BOU1
|
PG |
|
R
|
Radiopharm Theranostics Ltd
ASX:RAD
|
AU |
|
Kingfish Company NV
F:93G
|
NL |
|
Braskem SA
F:BRD
|
BR |
|
T
|
Thor Medical ASA
SWB:8NN
|
NO |
|
Toyo Corp
F:TOY
|
JP |
|
Signify NV
AEX:LIGHT
|
NL |
|
E
|
EUROKAI GmbH & Co KgaA
F:EUK3
|
DE |
|
T
|
TPI Polene Power PCL
SET:TPIPP
|
TH |
|
Futura Medical PLC
F:GYX
|
UK |
|
A
|
ASEC International Corp
TPEX:6113
|
TW |
|
Iren SpA
F:TZ8
|
IT |
|
S
|
Solusi Bangun Indonesia Tbk PT
F:RU6
|
ID |
|
Indutrade AB
OTC:IDTRY
|
SE |
|
H
|
Highnoon Laboratories Ltd
KAR:HINOON
|
PK |
Bankruptcy Probability
Actinogen Medical Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Actinogen Medical Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Actinogen Medical Ltd
ASX:ACW
|
204.4m AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
481.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
182.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
127.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
78.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Actinogen Medical Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Actinogen Medical Ltd has total debt of 87.4k AUD. This includes both short-term (0 AUD) and long-term (87.4k AUD) debt.
You can find a full breakdown on its Balance Sheet.